Jacek Kwiecinski1, Damini Dey2, Sebastien Cadet2, Sang-Eun Lee3, Yuka Otaki2, Phi T Huynh2, Mhairi K Doris4, Evann Eisenberg2, Mijin Yun3, Maurits A Jansen4, Michelle C Williams4, Balaji K Tamarappoo2, John D Friedman2, Marc R Dweck2, David E Newby4, Hyuk-Jae Chang3, Piotr J Slomka2, Daniel S Berman5. 1. Department of Imaging (Division of Nuclear Medicine), Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. 2. Department of Imaging (Division of Nuclear Medicine), Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California. 3. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea. 4. BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. 5. Department of Imaging (Division of Nuclear Medicine), Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: Daniel.Berman@cshs.org.
Abstract
OBJECTIVES: This study aimed to assess the association between increased lesion peri-coronary adipose tissue (PCAT) density and coronary 18F-sodium fluoride (18F-NaF) uptake on positron emission tomography (PET) in stable patients with high-risk coronary plaques (HRPs) shown on coronary computed tomography angiography (CTA). BACKGROUND: Coronary 18F-NaF uptake reflects the rate of calcification of coronary atherosclerotic plaque. Increased PCAT density is associated with vascular inflammation. Currently, the relationship between increased PCAT density and 18F-NaF uptake in stable patients with HRPs on coronary CTA has not been characterized. METHODS: Patients who underwent coronary CTA were screened for HRP, which was defined by 3 concurrent plaque features: positive remodeling; low attenuation plaque (LAP) (<30 Hounsfield units [HU]) and spotty calcification; and obstructive coronary stenosis ≥50% (plaque volume >100 mm3). Patients with HRPs were recruited to undergo 18F-NaF PET/CT. In lesions with stenosis ≥25%, quantitative plaque analysis, mean PCAT density, maximal coronary motion-corrected 18F-NaF standard uptake values (SUVmax), and target-to-background ratios (TBR) were measured. RESULTS: Forty-one patients (age 65 ± 6 years; 68% men) were recruited. Fifty-one lesions in 23 patients (56%) showed increased coronary 18F-NaF activity. Lesions with 18F-NaF uptake had higher surrounding PCAT density than those without 18F-NaF uptake (-73 HU; interquartile range -79 to -68 HU vs. -86 HU; interquartile range -94 to -80 HU; p < 0.001). 18F-NaF TBR and SUVmax were correlated with PCAT density (r = 0.63 and r = 0.68, respectively; all p < 0.001). On adjusted multiple regression analysis, increased lesion PCAT density and LAP volume were associated with 18F-NaF TBR (β = 0.25; 95% confidence interval: 0.17 to 0.34; p < 0.001 for PCAT, and β = 0.07; 95% confidence interval: 0.03 to 0.11; p = 0.002 for LAP). CONCLUSIONS: In patients with HRP features on coronary CTA, increased density of PCAT was associated with focal 18F-NaF PET uptake. Simultaneous assessment of these imaging biomarkers by 18F-NaF PET and CTA might refine cardiovascular risk prediction in stable patients with HRP features.
OBJECTIVES: This study aimed to assess the association between increased lesion peri-coronary adipose tissue (PCAT) density and coronary 18F-sodium fluoride (18F-NaF) uptake on positron emission tomography (PET) in stable patients with high-risk coronary plaques (HRPs) shown on coronary computed tomography angiography (CTA). BACKGROUND: Coronary 18F-NaF uptake reflects the rate of calcification of coronary atherosclerotic plaque. Increased PCAT density is associated with vascular inflammation. Currently, the relationship between increased PCAT density and 18F-NaF uptake in stable patients with HRPs on coronary CTA has not been characterized. METHODS: Patients who underwent coronary CTA were screened for HRP, which was defined by 3 concurrent plaque features: positive remodeling; low attenuation plaque (LAP) (<30 Hounsfield units [HU]) and spotty calcification; and obstructive coronary stenosis ≥50% (plaque volume >100 mm3). Patients with HRPs were recruited to undergo 18F-NaF PET/CT. In lesions with stenosis ≥25%, quantitative plaque analysis, mean PCAT density, maximal coronary motion-corrected 18F-NaF standard uptake values (SUVmax), and target-to-background ratios (TBR) were measured. RESULTS: Forty-one patients (age 65 ± 6 years; 68% men) were recruited. Fifty-one lesions in 23 patients (56%) showed increased coronary 18F-NaF activity. Lesions with 18F-NaF uptake had higher surrounding PCAT density than those without 18F-NaF uptake (-73 HU; interquartile range -79 to -68 HU vs. -86 HU; interquartile range -94 to -80 HU; p < 0.001). 18F-NaF TBR and SUVmax were correlated with PCAT density (r = 0.63 and r = 0.68, respectively; all p < 0.001). On adjusted multiple regression analysis, increased lesion PCAT density and LAP volume were associated with 18F-NaF TBR (β = 0.25; 95% confidence interval: 0.17 to 0.34; p < 0.001 for PCAT, and β = 0.07; 95% confidence interval: 0.03 to 0.11; p = 0.002 for LAP). CONCLUSIONS: In patients with HRP features on coronary CTA, increased density of PCAT was associated with focal 18F-NaF PET uptake. Simultaneous assessment of these imaging biomarkers by 18F-NaF PET and CTA might refine cardiovascular risk prediction in stable patients with HRP features.
Authors: Jacek Kwiecinski; Daniel S Berman; Sang-Eun Lee; Damini Dey; Sebastien Cadet; Martin L Lassen; Guido Germano; Maurits A Jansen; Marc R Dweck; David E Newby; Hyuk-Jae Chang; Mijin Yun; Piotr J Slomka Journal: J Nucl Med Date: 2018-09-13 Impact factor: 10.057
Authors: Sandeep Hedgire; Vinit Baliyan; Evan J Zucker; Daniel O Bittner; Pedro V Staziaki; Richard A P Takx; Jan-Erik Scholtz; Nandini Meyersohn; Udo Hoffmann; Brian Ghoshhajra Journal: Radiology Date: 2018-02-05 Impact factor: 11.105
Authors: Nitesh Nerlekar; Francis J Ha; Caitlin Cheshire; Hashrul Rashid; James D Cameron; Dennis T Wong; Sujith Seneviratne; Adam J Brown Journal: Circ Cardiovasc Imaging Date: 2018-01 Impact factor: 7.792
Authors: Michaela M Hell; Manish Motwani; Yuka Otaki; Sebastien Cadet; Heidi Gransar; Romalisa Miranda-Peats; Jacob Valk; Piotr J Slomka; Victor Y Cheng; Alan Rozanski; Balaji K Tamarappoo; Sean Hayes; Stephan Achenbach; Daniel S Berman; Damini Dey Journal: Eur Heart J Cardiovasc Imaging Date: 2017-12-01 Impact factor: 6.875
Authors: Mathieu Rubeaux; Nikhil V Joshi; Marc R Dweck; Alison Fletcher; Manish Motwani; Louise E Thomson; Guido Germano; Damini Dey; Debiao Li; Daniel S Berman; David E Newby; Piotr J Slomka Journal: J Nucl Med Date: 2015-10-15 Impact factor: 10.057
Authors: Andrew Lin; Márton Kolossváry; Jeremy Yuvaraj; Sebastien Cadet; Priscilla A McElhinney; Cathy Jiang; Nitesh Nerlekar; Stephen J Nicholls; Piotr J Slomka; Pál Maurovich-Horvat; Dennis T L Wong; Damini Dey Journal: JACC Cardiovasc Imaging Date: 2020-08-26
Authors: Christina H Liu; Natalie D Abrams; Danielle M Carrick; Preethi Chander; Johanna Dwyer; Michelle R J Hamlet; Andrei L Kindzelski; Mercy PrabhuDas; Shang-Yi Anne Tsai; Merriline M Vedamony; Chiayeng Wang; Pushpa Tandon Journal: FASEB J Date: 2019-10-09 Impact factor: 5.834
Authors: Jacek Kwiecinski; Evangelos Tzolos; Mohammed N Meah; Sebastien Cadet; Philip D Adamson; Kajetan Grodecki; Nikhil V Joshi; Alastair J Moss; Michelle C Williams; Edwin J R van Beek; Daniel S Berman; David E Newby; Damini Dey; Marc R Dweck; Piotr J Slomka Journal: J Nucl Med Date: 2021-04-23 Impact factor: 11.082
Authors: Jeremy Yuvaraj; Kevin Cheng; Andrew Lin; Peter J Psaltis; Stephen J Nicholls; Dennis T L Wong Journal: Cells Date: 2021-05-13 Impact factor: 6.600